GLP-1 Key Research Facts Full name: Glucagon-Like Peptide-1 incretin hormone of the proglucagon family Primary bioactive form: GLP-1(736)amide 30 amino acids, C-terminally amidated Gene source: Proglucagon gene processed by PCSK1 in intestinal L-cells and brainstem NTS neurons In vivo half-life: Approximately 12 minutes rapidly inactivated by DPP-4 (cleaves His7-Ala8 dipeptide) Primary receptor: GLP-1R (GLP-1 receptor) class B G protein-coupled receptor (GPCR) Signalling: GLP-1R activation cAMP elevation PKA/CREB activation glucose-dependent insulin secretion Additional signalling: PI3K/Akt pathway -cell survival, proliferation, and glucose sensitivity Secretion pattern: Biphasic post-meal release from intestinal L-cells early neural/endocrine peak + late direct nutrient-contact peak Fasting plasma level: ~510 pmol/L
Your personal response depends on genetics, diet, exercise, sleep, stress, and dozens of other variables that clinical trial averages cannot capture
Patients should be educated about recognising hypoglycaemia symptoms including trembling, sweating, confusion, and palpitationsand the importance of carrying fast-acting carbohydrates
Compounded semaglutide has not been reviewed by Health Canada for safety, quality or efficacy
Unlike direct synthetic growth hormone therapy, Sermorelin supports your bodys own regulatory mechanisms, which reduces the risk of side effects like joint pain, swelling, or changes in blood sugar
Looking forward to buying more when I can afford it